Q1 2020 Swedish Orphan Biovitrum AB (publ) Earnings Call Transcript
Ladies and gentlemen, welcome to the Sobi presentation of the Q1 results. (Operator Instructions)
I will now hand over to Guido Oelkers, CEO. Please go ahead.
()-&
Yes. Welcome, everybody. It's really a great pleasure to have you here on the Sobi call knowing that we are competing with quite another -- quite a few other earnings calls. So I go right into it. We'll start with the forward-looking statement as per usual, and please take note of this. And then I come to the presenters of today, this is Henrik, our CFO; and Milan, our Head of R&D, who will join me for this call.
And with this having said, these are obviously unprecedented times, so I go to Slide #4, and very challenging times. So before we talk about our very significant top line and -- top and bottom line growth, just wanted to tell you that we absolutely take this situation very seriously and take charge. So for us, the first priority was to make sure that
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
